The analysis of global export of oestrogens and progestogens in 2023 indicated that China was the dominant exporter, accounting for 58.57% of global exports by volume. Other significant contributors included Belgium and the United States with shares of 11.05% and 9.02%, respectively. Notable year-on-year growth was observed in South Korea (310.42%) and Slovenia (33.12%), while countries like Greece and Switzerland experienced declines of 16.37% and 5.85%, respectively. Over the past five years, shifts have generally shown a trend towards increased diversification with emergent markets beginning to gain traction.
In the future, global export trends of oestrogens and progestogens are likely to be influenced by technological advancements in hormone production and regulation, evolving consumer needs and preferences, and shifting regulatory landscapes. Close attention should be given to the emerging markets, particularly in Asia and Eastern Europe, as they could alter the current market dynamics significantly over the coming years.
Top countries in Export of Oestrogens and Progestogens Share by Country (Kilograms)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 58.57 | 2023 | +2.94% | +2.85% | View data |
| 2 | 2 Belgium | 11.05 | 2023 | +3.91% | +4.64% | View data |
| 3 | 3 United States | 9.02 | 2023 | +1.78% | +2.11% | View data |
| 4 | 4 Italy | 6.18 | 2023 | +2.81% | +2.25% | View data |
| 5 | 5 Singapore | 2.92 | 2023 | +4.73% | +6.52% | View data |
| 6 | 6 Netherlands | 2.87 | 2023 | -0.69% | -2.22% | View data |
| 7 | 7 Switzerland | 2.03 | 2023 | -0.77% | -5.85% | View data |
| 8 | 8 Spain | 1.22 | 2023 | +0.86% | +1.69% | View data |
| 9 | 9 Germany | 1.14 | 2023 | -5.92% | -6.4% | View data |
| 10 | 10 Greece | 0.13 | 2023 | +3.41% | -16.37% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...